Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Edap Tms SA EDAP

Edap Tms SA is a France-based company that develops, manufactures, promotes and distributes minimally invasive medical devices for urology based upon ultrasound technology. The Company's activity is organized in two divisions: HIFU (High Intensity Focused Ultrasound) and ESWL (Extracorporeal ShockWave Lithotripsy) that invests in research and development, partnering with INSERM French public... see more

Recent & Breaking News (NDAQ:EDAP)

EDAP TMS SA Closes $11.5 Million Registered Direct Offering

GlobeNewswire April 14, 2016

EDAP TMS SA to Raise $11.5 Million in Registered Direct Offering

GlobeNewswire April 7, 2016

EDAP Submits 510(k) Application for FDA Clearance of Focal One HIFU

GlobeNewswire April 6, 2016

EDAP Reports 20% Revenue Growth to EUR 32.3 Million and EUR 0.5 Million Operating Profit for Full-year 2015

GlobeNewswire April 4, 2016

EDAP to Report Fourth Quarter and Full Year 2015 Results on April 4, 2016

GlobeNewswire March 24, 2016

EDAP HIFU Advancements Highlighted at International Symposium on Therapeutic Ultrasound

GlobeNewswire March 22, 2016

EDAP HIFU and Lithotripsy Devices Showcased at 31st Annual European Association of Urology Congress

GlobeNewswire March 17, 2016

EDAP Announces Sylvester Comprehensive Cancer Center in Miami as First Certified U.S. Ablatherm® Robotic HIFU Site

GlobeNewswire March 10, 2016

First Patients Treated With EDAP's Ablatherm® Robotic HIFU in New York

GlobeNewswire March 7, 2016

First Prostate Ablation Treatments Performed Using EDAP's FDA Approved Ablatherm® Robotic HIFU at Sylvester Comprehensive Cancer Center, in Miami, Florida

GlobeNewswire January 25, 2016

EDAP Announces Results of World's First Focal HIFU Trial

GlobeNewswire January 19, 2016

EDAP Receives Japanese Approval for Quanta Litho Laser; Secures Exclusive Distribution Rights in Japan

GlobeNewswire January 6, 2016

EDAP Reports Sale of Ablatherm Robotic HIFU to Sylvester Comprehensive Cancer Center

GlobeNewswire December 21, 2015

EDAP Receives Russian Regulatory Approval for Focal One(R) HIFU Device

GlobeNewswire December 11, 2015

EDAP Reports Installation of Ablatherm Robotic HIFU at University of Southern California

GlobeNewswire December 9, 2015

Positive Outcomes From Prostate Cancer Hemiablation Study With EDAP Ablatherm Robotic HIFU Presented at 109th French Urology Congress

GlobeNewswire November 24, 2015

Direction of Market Influences - Research on EVINE Live, hhgregg, Abeona Therapeutics and Edap Tms

Accesswire November 23, 2015

EDAP Reports Third Quarter 2015 Financial Results and Operational Update

GlobeNewswire November 18, 2015

EDAP to Hold Third Quarter 2015 Conference Call on November 19, 2015

GlobeNewswire November 12, 2015

EDAP Records First Three U.S. Orders for Ablatherm HIFU

GlobeNewswire November 12, 2015